Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.

Date
2018
Author
Emet, Samim
ARMAN, Yusuf
Cakmak, R.
Tukek, Tufan
OZGUN, Ersin
Alibeyoglu, A.
YURUYEN, G.
AKARSU, M.
OZCAN, M.
ALTUN, O.
Kose, M.
Onur, I.
Atici, A.
Metadata
Show full item record
Abstract
OBJECTIVE: Type 1 cardiorenal syndrome (CRS) is an acute renal failure in patients with acute decompensated heart failure with an incidence of 24% to 45%. The aim of our study was to investigate the significance of new renal biomarkers to predict type 1 CRS.
URI
http://hdl.handle.net/20.500.12627/68208
https://doi.org/10.26355/eurrev_201806_15180
Collections